Medical Researech
-
The microbiologist, on the faculty for nearly half a century, studied a wide range of topics, including antibiotic resistance, cancer, and bacteria as an agent for cleaning up toxic chemicals.
-
Cell-based therapy for solid tumors
The FDA recently approved the first cell-based therapy — widely used in treating blood cancers — for solid tumors. Stanford Medicine treated the first patient with advanced melanoma.
-
Studying neurodevelopmental disorders
Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.
-
New epilepsy target
Researchers find that a little-understood part of the brain appears to be involved in starting seizures and keeping them going.
-
Elizabeth Mellins dies
Mellins, who studied autoimmune disease and co-founded a large pediatric rheumatology research network, was a tireless mentor and advocate for her field.
-
Psychosis starts in two brain systems
When the brain has trouble filtering incoming information and predicting what’s likely to happen, psychosis can result, Stanford Medicine-led research shows.
-
AI advice helps skin cancer diagnoses
Artificial intelligence algorithms powered by deep learning improve skin cancer diagnostic accuracy for doctors, nurse practitioners and medical students in a study led by the Stanford Center for Digital Health.
-
Unexpected cells may spread COVID-19
A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine scientists have found. The discovery has important implications for preventing severe COVID-19.
-
Virtual biopsy shows promise
Stanford Medicine researchers develop a new imaging method to create a cell-by-cell reconstruction of skin or other tissue without taking a biopsy.
-
Keto diet helps mental illness
A small clinical trial led by Stanford Medicine found that the metabolic effects of a ketogenic diet may help stabilize the brain.
-
AI tackles antibiotic resistance
Stanford Medicine researchers devise a new artificial intelligence model, SyntheMol, which creates recipes for chemists to synthesize the drugs in the lab.
-
One treatment improves vaccine response
Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Stanford Medicine researchers were able to revitalize the immune system in mice.
- Artificial Intelligence (AI)
- Addiction
- Aging & Geriatrics
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Awards & Honors
- Biochemistry
- Bioengineering
- Blood Disorders (Hematology)
- Cancer
- Cardiology
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Dermatology
- Diabetes
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Endocrinology
- Environment & Sustainability
- Epidemiology & Population Health
- Ethics
- Genetics
- Global Health
- Health Policy
- Immunology
- Infectious Disease
- Innovation & Technology
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Microbiology
- Neurobiology
- Neurology & Neurosurgery
- Nutrition
- Obituaries
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedics
- Palliative Care
- Pathology
- Pediatrics
- Physiology
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Radiology
- Stanford Medicine
- Stem Cells
- Surgery
- Transplantation
- Urology
- Vaccines
- Wellness
- Women's Health